Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Boston Scientific Corp (BSX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 49,905,044
  • Shares Outstanding, K 1,390,500
  • Annual Sales, $ 9,823 M
  • Annual Income, $ 1,671 M
  • 60-Month Beta 0.87
  • Price/Sales 4.94
  • Price/Cash Flow 16.17
  • Price/Book 5.54

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 18 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/19
See More
  • Average Estimate 0.36
  • Number of Estimates 11
  • High Estimate 0.36
  • Low Estimate 0.35
  • Prior Year 0.33
  • Growth Rate Est. (year over year) +9.09%

Price Performance

See More
Period Period Low Period High Performance
1-Month
34.35 +3.39%
on 04/18/19
39.00 -8.95%
on 04/01/19
-1.79 (-4.80%)
since 03/22/19
3-Month
34.35 +3.39%
on 04/18/19
41.00 -13.39%
on 03/04/19
-1.72 (-4.62%)
since 01/24/19
52-Week
27.91 +27.23%
on 04/25/18
41.00 -13.39%
on 03/04/19
+7.01 (+24.60%)
since 04/24/18

Most Recent Stories

More News
Boston Scientific (BSX) Misses Q1 Earnings, Tightens EPS View

Boston Scientific (BSX) is investing in new technologies and the global markets, which in turn, aids the uptick in sales across its most geographies in Q1.

VAR : 133.27 (+0.27%)
BSX : 35.44 (-1.25%)
BIO : 293.78 (-0.46%)
ICUI : 227.88 (+1.24%)
Option-trading opportunities on Boston Scientific Corp., Kohl's Corp., Netflix Inc., PG&E Corp., and Procter & Gamble Co.

InvestorsObserver issues critical PriceWatch Alerts for BSX, KSS, NFLX, PCG, and PG.

NFLX : 374.23 (-2.01%)
PCG : 22.93 (+6.50%)
BSX : 35.44 (-1.25%)
PG : 103.69 (+0.51%)
KSS : 73.28 (-2.91%)
Boston Scientific: 1Q Earnings Snapshot

MARLBOROUGH, Mass. (AP) — Boston Scientific Corp. on Wednesday reported first quarter net income of $424 million.

BSX : 35.44 (-1.25%)
Boston Scientific Announces Results For First Quarter 2019

Boston Scientific Corporation (NYSE: BSX) generated sales of $2.493 billion during the first quarter of 2019. This represents growth of 4.8 percent on a reported basis, 7.8 percent on an operational1 basis...

BSX : 35.44 (-1.25%)
Boston Scientific Receives FDA Approval for LOTUS Edge(TM) Aortic Valve System

Boston Scientific Corporation (NYSE: BSX) today announced it has received U.S. Food and Drug Administration (FDA) approval for the LOTUS Edge(TM) Aortic Valve System. Delivered via a minimally-invasive...

BSX : 35.44 (-1.25%)
Boston Scientifc (BSX) Breaks Through Resistance at $35.13

Shares of Boston Scientifc (NYSE:BSX) opened today above their pivot of $34.91 and have already reached the first level of resistance at $35.13. Analysts will be watching for a cross of the next upside...

BSX : 35.44 (-1.25%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Boston Scientific Corporation - BSX

Pomerantz LLP is investigating claims on behalf of investors of Boston Scientific Corporation ("Boston Scientific" or the "Company") (NYSE: BSX). Such investors are advised to contact Robert S. Willoughby...

BSX : 35.44 (-1.25%)
Can Boston Scientific's (BSX) Steady Growth Aid Q1 Earnings?

We are optimistic about Boston Scientific's (BSX) IC business that will help maintain its impressive global growth trend in Q1 owing to an innovative portfolio and strong commercial teams.

CERN : 64.15 (+0.50%)
BSX : 35.44 (-1.25%)
TMO : 261.56 (-0.89%)
GWPH : 161.03 (-2.74%)
Global Neuromodulation Markets 2019-2024 Featuring Major Players - Medtronic, Boston Scientific, St. Jude Medical, Synapse Biomedical, and Nevro

The "Neuromodulation Market - Growth, Trends, and Forecast (2019 - 2024)" report has been added to ResearchAndMarkets.com's offering.

BSX : 35.44 (-1.25%)
STJ : 80.82 (+0.16%)
MDT : 85.64 (+0.63%)
Option-trading opportunities on Boston Scientific Corp., DowDuPont Inc., HP Inc., Marvell Technology, and Netflix Inc.

InvestorsObserver issues critical PriceWatch Alerts for BSX, DWDP, HPQ, MRVL, and NFLX.

NFLX : 374.23 (-2.01%)
BSX : 35.44 (-1.25%)
HPQ : 19.87 (-1.10%)
DWDP : 38.29 (+0.03%)
MRVL : 25.47 (+1.39%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Sell with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators mostly agree with the trend.

See More Share

Trade BSX with:

Business Summary

Boston Scientific Corporation transforms lives through innovative medical solutions that improve the health of patients around the world. As a global medical technology leader they advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce...

See More

Key Turning Points

2nd Resistance Point 36.52
1st Resistance Point 36.20
Last Price 35.44
1st Support Level 35.27
2nd Support Level 34.65

See More

52-Week High 41.00
Fibonacci 61.8% 36.00
Last Price 35.44
Fibonacci 50% 34.46
Fibonacci 38.2% 32.91
52-Week Low 27.91

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar